Skip to content
Vigorous Solutions
  • About Us
  • Pipeline
  • News
  • Partners
  • Contact Us
Vigorous Solutions
  • About Us
  • Pipeline
  • News
  • Partners
  • Contact Us

News

Mexico patent protection granted

By vsiadmin | October 2019

Mexican patent office grants patent protection for Vigorous Solutions fast-acting sildenafil solutions

Read More

China patent protection granted

By vsiadmin | July 2019

Chinese National Intellectual Property Administration grants patent protection for Vigorous Solutions novel fast-acting sildenafil solutions

Read More

Patent protection granted for Eurasian countries

By vsiadmin | April 2019

Eurasian patent protection for Vigorous Solutions sildenafil solutions is granted in Russia, Turkmenistan, Belarus, Tajikistan, Azerbaijan, Kazakhstan, Kyrgyzstan, and Armenia

Read More

Patent granted in Israel

By vsiadmin | March 2019

Israel Patent Authority issues notice of allowance for Vigorous Solutions novel sildenafil solution products

Read More

Second Clinical Trial Completed

By vsiadmin | January 2019

Second pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation as the fastest absorbed and highest bioavailable Sildenafil product

Read More

Second U.S. Patent Granted

By vsiadmin | December 2018

Vigorous Solutions receives a second U.S. patent allowance, issued to expand the protection of its proprietary liquid sildenafil formulations

Read More

First U.S. Patent Granted

By vsiadmin | May 2018

Vigorous Solutions is issued its first U.S. patent allowance, covering an expansive variety of liquid solutions

Read More

European Patent Registration Complete

By vsiadmin | April 2018

European patent registers Vigorous Solutions product in all 38 European countries

Read More

European Patent Allowance

By vsiadmin | March 2018

Grant Patent issued to Vigorous Solutions by the European Patent Office

Read More

First Clinical Trial Completed

By vsiadmin | January 2018

First pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation’s superiority in time-to-absorption vs Pfizer’s Viagra®.

Read More
Older Posts »

Recent Posts

  • Mexico patent protection granted
  • China patent protection granted
  • Patent protection granted for Eurasian countries
  • Patent granted in Israel
  • Second Clinical Trial Completed

Recent Comments

    Archives

    • October 2019
    • July 2019
    • April 2019
    • March 2019
    • January 2019
    • December 2018
    • May 2018
    • April 2018
    • March 2018
    • January 2018
    • December 2017
    • April 2017

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Terms of Use & Privacy Policy
    © 2017-2023 Vigorous Solutions Ltd.
    Member of
    Drug Rediscovery Group Ltd.

    Want to stay up to date with Vigorous Solutions latest news and information?
    Subscribe to our mailing list and please be sure to click the link you receive in your email to complete your subscription.